Home › Bulimia Nervosa › NCT05614024
Neurofeedback During Eating for Bulimia Nervosa
Neurofeedback During Eating: A Novel Mechanistic Treatment for Bulimia Nervosa
Who can join
Ages 18 to 45 · Women
Full eligibility criteria
Inclusion criteria: * Female * Aged 18 to 45 years * Meet diagnostic criteria for bulimia nervosa * Current body mass index greater than or equal to 18.5kg/m2 but under 30kg/m2 * English-speaking Exclusion criteria: * Ongoing medical treatment, major medical condition, or psychiatric disorder that may interfere with study variables or participation * Current psychotherapy focused primarily on eating disorder symptoms * Pregnancy or planned pregnancy, or lactation during the study period * Allergy to ingredients in the standardized meal or in the shake
About the study
The purpose of this study is to examine the effects of noninvasive prefrontal cortex (PFC) neurofeedback during eating in women with bulimia nervosa (BN) using a wearable brain imaging device, functional near-infrared spectroscopy (fNIRS). The investigators will examine how this training may influence inhibitory control and BN symptoms.
What is being tested
- Real fNIRS Neurofeedback (other)
- Sham-Control fNIRS Neurofeedback (other)
Sponsor: Icahn School of Medicine at Mount Sinai · Participants: 30 · Started: May 13, 2024
Contact the study team
- Sila Sozeri, B.A. · Phone: (212) 201-2679
Official record on ClinicalTrials.gov — NCT05614024
Locations in the U.S.
| New York | Center for Computational Psychiatry at the Icahn School of Medicine at Mount Sinai, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.